Please complete this pretest survey and press "done" within this window, then answer the confirmation question below this window and press "Click Here to Continue" to advance to the content.

Question Title

* 1. How confident are you in the management of patients with CRSwNP in your practice?

Question Title

* 2. Which tool do you primarily use in your current practice to assess a patient’s quality of life?

Question Title

* 3. Which of the following is a more disease-specific questionnaire for CRSwNP?

Question Title

* 4. According to EPOS2020, in order to meet criteria for need of systemic corticosteroids in consideration of biologic treatment for CRSwNP, the patient should have which of the following?

Question Title

* 5. Tom is a 45-year-old male who has a diagnosis of CRSwNP and is currently taking a medium-dose ICS for his asthma. He has been treated with EDS-FLU and was previously on daily nasal steroid. He underwent FESS after losing his ability to smell and experiencing lack of sleep due to his nasal congestion. Smell and sleep returned after FESS, but have since reoccurred. What would be the most appropriate recommendation for this patient based on EUFOREA guidelines?

Question Title

* 6. In an indirect comparison of available biologics for CRSwNP, which therapy demonstrated greatest effect on improving sense of smell and in reduction in SNOT-22 scores, need for surgery, and need for OCS vs standard of care?

T